References
- Hammer SP. Common lung neoplasms. Pulmonary Pathology, DH. Dail, SP. Hammer. Springer-Verlag, New York 1988; 727–845
- Minna JD., Pass H, Glatstein E, Ihde D. Cancer of the lung. Cancer Principles and Practice of Oncology, 3rd ed, VT. Devita, S Hellman, SA. Rosenberg. Lippincott, Philadelphia 1989; 591–631
- Rilke F, Carbone A, Clemente C, et al. Surgical Pathology of resectable lung cancer. Prog Cancer Res Ther 1979; 11: 129–142
- Hirsch FR., Matthews MJ., Yesner R. Histopathologic classification of small cell carcinoma of lung: Comments based on an in-terobserver examination. Cancer 1983; 50: 1360–1366
- Yesner R. Observer variability and reliability in lung cancer diagnosis. Cancer Chemother Rep 1973; 4: 55–57
- Ashley D JB, Davies HD. Mixed glandular and squamous carcinoma of the bronchus. Thorax 1967; 22: 431–436
- Fitzgibbons PL., Kern WH. Adenosquamous carcinoma of the lung: A clinical and pathological study of seven cases. Hum Pathol 1985; 16: 463–466
- Sridhar KS., Bounassi MJ., Raub WA., Jr, Richman SP. Clinical features of adenosquamous lung carcinoma in 127 patients. Am Rev Respir Dis 1990; 142: 19–23
- World Health Organization. The World Health Organization Histological typing of Lung Tumors. Am J Clin Pathol 1982; 77: 123–136
- Sridhar KS., Raub WA., Jr, Duncan RC., Hilsenbeck S, Richman SP. Lung carcinoma in 1336 patients. Am J Clin Oncol 1991; 14: 496–508
- Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378–382
- Fleiss JL. The measurement of interrater agreement. Statistical Methods for Rates and Proportions, 2nd ed, JL. Fleiss. Wiley, New York 1981; 212–234
- Landis JR., Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174
- Yesner R, Gerstl B, Auerbach O. Application of the World Health Organization classification of lung carcinoma to biopsy material. Ann Thorac Surg 1965; 1: 33–49
- Feinstein AR., Gelfman NA., Yesner R. Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis 1970; 101: 671–684
- Jacques J, Hill DP., Shier KJ., Jindani A, Miller AB. Appraisal of the World Health Organization classification of lung tumors. Can Med Assoc J 1980; 122: 897–901
- Stanley KE., Matthews MJ. Analysis of a pathology review of patients with lung tumors. J Natl Cancer Institute 1981; 66: 989–992
- Hanai A, Whittaker JS., Tateishi R, et al. Concordance of histo-logical classification of lung cancer with special reference to ad-enocarcinoma in Osaka, Japan and the Northwest region of England. Int J Cancer 1987; 39: 6–9
- Dale I, Skjorten F, Stenwig JT., Lexow P, Brandtzaeg P. Repro-ducibility of tumor typing of lung carcinomas performed according to WHO's recommendations. Acta Pathol Microbiol et Immunol Scand 1989; 97: 351–356
- Hinson K FW, Miller AB., Tall R. An assessment of the World Health Organization classification of the histologic typing of lung tumors applied to biopsy and resected material. Cancer 1975; 35: 399–405
- Slebos R JC, Kibbelaar RE., Dalesio O, et al. K.-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561–564
- Graziano SL., Mazid R, Newman N, et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. J Clin Oncol 1989; 7: 1398–1406
- Zimmerman PV., Bint MH., Hanson GA., et al. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987; 2: 530–533
- Ichinose Y, Hara N, Ohta M, et al. Postoperative adjuvant chemotherapy in non-small cell lung cancer. Prognostic value of DNA ploidy and postcurrent survival. J Surg Oncol 1991; 46: 15–20
- Lee JS., Ro JY., Sahin AA., et al. Expression of blood group antigen A—A favorable prognostic factor in non-small cell lung cancer. N Engl J Med 1991; 324: 1084–1090